comparemela.com
Home
Live Updates
XORTX Provides Corporate Update | MarketScreener : compareme
XORTX Provides Corporate Update | MarketScreener : compareme
XORTX Provides Corporate Update | MarketScreener
CALGARY, Alberta, Jan. 31, 2022 -- XORTX Therapeutics Inc. , a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to... | January 31, 2022
Related Keywords
Colorado ,
United States ,
Canada ,
American ,
Canadian ,
Raymond Pratt ,
Nick Rigopulos ,
Allen Davidoff ,
Charles Edelstein ,
Jacqueline Le Saux ,
Stephen Haworth ,
Amar Keshri ,
Bill Farley ,
Business Development At Chemdiv ,
European Patent Office ,
Wuxi Apptec Inc ,
American Society Of Nephrology Advisory Committee Member ,
Nasdaq ,
Pfizer ,
Therapeutics Inc ,
European Union ,
Canadian Securities Exchange ,
Venture Exchange ,
Globenewswire Inc ,
Rockwell Medical Inc ,
Drug Administration ,
Alliance Global Partners ,
American Federation Of Clinical Research ,
International Society Of Nephrology ,
Exchange Commission ,
Prevention Of Hyperuricemia Related Health Consequences ,
University Of London ,
University Of Colorado ,
Company Management Discussion ,
Ernst Young ,
European Medicines Agency ,
Icahn School Of Medicine ,
University College Hospital Medical School ,
Hitgen Ltd ,
Sinai Hospital ,
Patent Office ,
Xanthine Oxidase ,
Enhancing Anti Viral ,
European Patent Grant ,
Hyperuricemia Related Health ,
Outcomes Associated ,
Hospitalized Patients ,
Vice President ,
Business Development ,
Chief Medical Officer ,
College Hospital Medical School ,
Chief Financial Officer ,
Chartered Professional Accountants ,
Clinical Advisory Board Member ,
Investigator Award ,
Western Section ,
Clinical Research ,
Nephrology Advisory Committee ,
Physician Executive ,
Chief Development Officer ,
Rockwell Medical ,
Global Partners ,
Orphan Drug Designation ,
New Drug Application ,
Medicines Agency ,
Orphan Drug ,
Investigative New Drug ,
Potential Commercial ,
Autosomal Dominant Polycystic Kidney Disease ,
Xortx Therapeutics Inc Stock Exchange ,
News ,
Information ,
Press Release ,
022 ,
Xortx ,
Herapeutics ,
Harmaceutical ,
Company ,
Ocused ,
N ,
Developing ,
Nnovative ,
Therapies ,
O ,
Treat ,
Progressive ,
Kidney ,
Us ,
Leased Xrx Ca98420q2071 ,